Faculty

Institution

Unit

Venue

Jon R. Wiener

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Molecular And Cellular Oncology

NoneJon R. Wiener is currently serving as a Molecular And Cellular Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jon R. Wiener

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

ovarian cancer gynecologic oncology tumor biology cell biology cancer biology gynecology oncology cancer cells cancer research gynecologic cancers oncogenes pharmacology cell signaling cancer growth molecular biology signal transduction receptor tyrosine kinases molecular cancer cellular biochemistry medicinal research tumor targeting cancer treatment cancer immunotherapy cellular physiology biological chemistry endocrine oncology protein phosphorylation breast oncology tumor suppressors cancer genetics ovarian cancer cells epithelial ovarian cancer cell growth regulation clinical lipidology vascular biology surgical oncology reproductive medicine cellular therapy proteome research redox biology cell death cancer risk cancer genomics biomedical research pharmaceutical sciences cell proliferation clinical medicine immunotoxicology tumor heterogeneity epidemiology of cancer cancer prevention signaling pathways protein function antibody engineering protein assembly protein x-ray crystallography multi-protein assembly cytokines cytogenetics biologic agents biological therapies protein purification lysophospholipid growth factors monokine induction paracrine growth factor tumor cell proliferation ptp1b protein ptp1b gene nude mouse model tyrosine phosphatase ptp1b human ovarian carcinomas heregulin suppress growth different mechanisms anti-her2 antibody cell regulatory proteins

Notable Scholarly Works

Notable Federal Grants

Collaborators

Nonreceptor Tyrosine Kinases and Their Roles in Cancer. (2011)

Lysophosphatidic Acid Induction of Urokinase Plasminogen Activator Secretion Requires Activation of the P38Mapk Pathway. International Journal of Oncology (2007)

receptorssignal transductionautophagybiological chemistrymolecular physiologyenzyme inhibitionbiochemistrycellular physiologymembrane proteinsmolecular pharmacologycell signalingmolecular biologycell biologymolecular and cellular biologycell deathcellular biochemistrycell and molecular biology

Activated Src Protein Tyrosine Kinase is Overexpressed in Late-Stage Human Ovarian Cancers. Gynecologic Oncology (2002)

Jon R WienerT.Christopher WindhamVeronica C EstrellaNila U ParikhPeter F ThallMichael T DeaversRobert C BastGordon B MillsGary E Gallick

tumor targetingcancer treatmentreceptor tyrosine kinasescancer researchoncologyovarian cancermolecular biologytumor biologycancer cellsgynecologic cancersgynecologic oncologygynecology

Critical Role of Lysophospholipids in the Pathophysiology, Diagnosis, and Management of Ovarian Cancer. Ovarian cancer (2002)

Gordon B. MillsAstrid EderXianjun FangYutaka HasegawaMuling MaoYiling LuJanos TanyiFazal Haq TabassamJon WienerRuth LapushinShiangxing YuJeff A. ParrottTim ComptonWalter TribleyDavid FishmanM. Sharon StackDouglas GaudetteRobert JaffeTatsuro FuruiJunken AokiJames R. Erickson

pharmacologypathologycancer biologyoncologyovarian cancerredox biologygynecologic oncologygynecologyendocrine oncology

Anti-Her2 Antibody and Heregulin Suppress Growth of Her2-Overexpressing Human Breast Cancer Cells Through Different Mechanisms.. PubMed (2000)

cancer biologytumor targetingmolecular cancerbreast cancercancer cellsoncogenesbreast oncologyheregulin suppress growthimmunologymedicinal researchanti-her2 antibodycell biologytherapeutic targetsdifferent mechanismscancer growth

Functional Evidence for an Ovarian Cancer Tumor Suppressor Gene on Chromosome 22 by Microcell-Mediated Chromosome Transfer. Oncogene (2000)

pathologycancer biologytumor suppressorsfunctional evidencecancer cellschromosome 22oncogenescell divisionovarian cancercancer geneticstumor biologycell biologygynecologic cancersgynecologic oncologycytogeneticsmicrocell-mediated chromosome transfer

Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer. Annals of the New York Academy of Sciences (2000)

XIANJUN FANGDOUGLAS GAUDETTETATSURO FURUIMULING MAOVERONICA ESTRELLAASTRID EDERTERRI PUSTILNIKTAKAYO SASAGAWARUTHIE LAPUSHINSHIANGXING YUROBERT B. JAFFEJON R. WIENERJAMES R. ERICKSONGORDON B. MILLS

ovarian cancersurgical oncologycell biologygynecologic oncologyendocrine oncologycancer biologycancer researchcancer genomicsmetastasistumor biologylysophospholipid growth factorsvascular biologypharmacologyoncologycancer riskhealth sciencesclinical lipidologymedicinal researchcancer growth

Decreased Src Tyrosine Kinase Activity Inhibits Malignant Human Ovarian Cancer Tumor Growth in a Nude Mouse Model.. PubMed (1999)

cancer biologynude mouse modelcancer cellsreceptor tyrosine kinasesoncogenesovarian cancertumor biologycarcinogenesiscell biologygynecologic cancersgynecologic oncologygynecologycancer growth

Lysophosphatidic Acid 181 Stimulates Urokinase Secretion in Ovarian Cancer Cells. Gynecologic Oncology (1999)

Lysophosphatidic Acid Induces Urokinase Secretion by Ovarian Cancer Cells.. PubMed (1999)

pharmacologycancer biologycancer cellssignal transductionovarian cancercellular physiologyovarian cancer cellscell signalingtumor biologycell biologycellular biochemistry

1
2
3
10 / page

Jon R. Wiener

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Molecular And Cellular Oncology

NoneJon R. Wiener is currently serving as a Molecular And Cellular Oncology faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Jon R. Wiener

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Nonreceptor Tyrosine Kinases and Their Roles in Cancer. (2011)

Lysophosphatidic Acid Induction of Urokinase Plasminogen Activator Secretion Requires Activation of the P38Mapk Pathway. International Journal of Oncology (2007)

Activated Src Protein Tyrosine Kinase is Overexpressed in Late-Stage Human Ovarian Cancers. Gynecologic Oncology (2002)

Jon R WienerT.Christopher WindhamVeronica C EstrellaNila U ParikhPeter F ThallMichael T DeaversRobert C BastGordon B MillsGary E Gallick

tumor targetingcancer treatmentreceptor tyrosine kinasescancer researchoncologyovarian cancermolecular biologytumor biologycancer cellsgynecologic cancersgynecologic oncologygynecology

Critical Role of Lysophospholipids in the Pathophysiology, Diagnosis, and Management of Ovarian Cancer. Ovarian cancer (2002)

pharmacologypathologycancer biologyoncologyovarian cancerredox biologygynecologic oncologygynecologyendocrine oncology

Anti-Her2 Antibody and Heregulin Suppress Growth of Her2-Overexpressing Human Breast Cancer Cells Through Different Mechanisms.. PubMed (2000)

Functional Evidence for an Ovarian Cancer Tumor Suppressor Gene on Chromosome 22 by Microcell-Mediated Chromosome Transfer. Oncogene (2000)

Lysophospholipid Growth Factors in the Initiation, Progression, Metastases, and Management of Ovarian Cancer. Annals of the New York Academy of Sciences (2000)

XIANJUN FANGDOUGLAS GAUDETTETATSURO FURUIMULING MAOVERONICA ESTRELLAASTRID EDERTERRI PUSTILNIKTAKAYO SASAGAWARUTHIE LAPUSHINSHIANGXING YUROBERT B. JAFFEJON R. WIENERJAMES R. ERICKSONGORDON B. MILLS

Decreased Src Tyrosine Kinase Activity Inhibits Malignant Human Ovarian Cancer Tumor Growth in a Nude Mouse Model.. PubMed (1999)

cancer biologynude mouse modelcancer cellsreceptor tyrosine kinasesoncogenesovarian cancertumor biologycarcinogenesiscell biologygynecologic cancersgynecologic oncologygynecologycancer growth

Lysophosphatidic Acid 181 Stimulates Urokinase Secretion in Ovarian Cancer Cells. Gynecologic Oncology (1999)

Lysophosphatidic Acid Induces Urokinase Secretion by Ovarian Cancer Cells.. PubMed (1999)

pharmacologycancer biologycancer cellssignal transductionovarian cancercellular physiologyovarian cancer cellscell signalingtumor biologycell biologycellular biochemistry

1
2
3
10 / page